Glycoprotein IIb/IIIa platelet receptor blockers: are they ready for prime time in patients with unstable coronary artery disease?
作者信息
Conti C R
出版信息
Clin Cardiol. 1999 Feb;22(2):57-8. doi: 10.1002/clc.4960220202.
Abstract
摘要
相似文献
1
Glycoprotein IIb/IIIa platelet receptor blockers: are they ready for prime time in patients with unstable coronary artery disease?
Clin Cardiol. 1999 Feb;22(2):57-8. doi: 10.1002/clc.4960220202.
2
[Use of platelet glycoprotein IIb/IIIa receptor inhibitors in acute coronary syndrome and coronary intervention].
Nihon Rinsho. 1998 Oct;56(10):2630-4.
3
Glycoprotein IIb/IIIa integrin blockade.
Circulation. 1998 Dec 8;98(23):2629-35. doi: 10.1161/01.cir.98.23.2629.
4
Safety of the use of IIb/IIIa receptor blockers with or without the use of other anticoagulants.
Semin Interv Cardiol. 1999 Jun;4(2):97-102. doi: 10.1053/siic.1999.0091.
5
An overview of the results of clinical trials with glycoprotein IIb/IIIa inhibitors.糖蛋白IIb/IIIa抑制剂临床试验结果概述。
Am Heart J. 1998 Apr;135(4):S43-55. doi: 10.1016/s0002-8703(98)70297-2.
6
Emerging treatment of acute coronary syndromes with platelet glycoprotein IIB/IIIA inhibitors.
J Thromb Thrombolysis. 1999 Jun;7(3):247-57. doi: 10.1023/a:1008927025962.
7
8
Glycoprotein IIb/IIIa antagonists in acute coronary syndromes.急性冠状动脉综合征中的糖蛋白IIb/IIIa拮抗剂
Haematologica. 2001 Nov;86(11 Suppl 2):45-8.
9
The clinical impact of platelet glycoprotein IIb/IIIa receptor blockade in cardiovascular medicine.血小板糖蛋白IIb/IIIa受体阻滞剂在心血管医学中的临床影响。
Jpn Circ J. 1998 Apr;62(4):233-43. doi: 10.1253/jcj.62.233.
10
Platelet inhibitors in non-ST-segment elevation acute coronary syndromes and percutaneous coronary intervention: glycoprotein IIb/IIIa inhibitors, clopidogrel, or both?非ST段抬高型急性冠脉综合征及经皮冠状动脉介入治疗中的血小板抑制剂：糖蛋白IIb/IIIa抑制剂、氯吡格雷，还是两者联用？
Vasc Health Risk Manag. 2006;2(1):39-48. doi: 10.2147/vhrm.2006.2.1.39.
引用本文的文献
1
The continuously evolving problems of acute ischemic coronary syndromes.急性缺血性冠状动脉综合征不断演变的问题。
Clin Cardiol. 1999 Oct;22(10):609-10. doi: 10.1002/clc.4960221003.
本文引用的文献
1
Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart disease.
Circulation. 1998;98(25):2829-35. doi: 10.1161/01.cir.98.25.2829.
2
Platelet glycoprotein IIB/IIIA receptor antagonists. An asset for treatment of unstable coronary syndromes and coronary intervention.血小板糖蛋白IIB/IIIA受体拮抗剂。治疗不稳定型冠状动脉综合征和冠状动脉介入治疗的一项有效手段。
Eur Heart J. 1998 Nov;19(11):1608-16. doi: 10.1053/euhj.1998.1222.
3
Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction.糖蛋白IIb/IIIa受体阻滞剂对急性心肌梗死患者冠状动脉支架置入术后冠状动脉血流恢复及左心室功能的影响。
Circulation. 1998 Dec 15;98(24):2695-701. doi: 10.1161/01.cir.98.24.2695.
4
Glycoprotein IIb/IIIa integrin blockade.
Circulation. 1998 Dec 8;98(23):2629-35. doi: 10.1161/01.cir.98.23.2629.
5
Unstable angina: an etiologic approach to management.
Circulation. 1998 Nov 24;98(21):2219-22. doi: 10.1161/01.cir.98.21.2219.
6
Rationale and clinical evidence for the use of GP IIb/IIIa inhibitors in acute coronary syndromes.急性冠状动脉综合征中使用糖蛋白IIb/IIIa抑制剂的理论依据及临床证据。
Am Heart J. 1998 Apr;135(4):S56-66. doi: 10.1016/s0002-8703(98)70298-4.
Zotero 插件